Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Syncona Shs GBP ( (GB:SYNC) ) has issued an announcement.
Syncona Limited announced that as of May 31, 2025, the total number of ordinary shares in issue is 672,214,632, with 62,920,067 shares held in treasury, resulting in 609,294,565 voting rights. This information is crucial for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
Spark’s Take on GB:SYNC Stock
According to Spark, TipRanks’ AI Analyst, GB:SYNC is a Neutral.
Syncona Shs GBP exhibits financial stability with a solid balance sheet and improved cash flow. However, revenue volatility and negative valuation metrics are significant challenges. The technical indicators suggest bearish trends, but the strategic share buyback program provides some positive momentum. Despite these strengths, valuation concerns and market challenges contribute to a mixed outlook.
To see Spark’s full report on GB:SYNC stock, click here.
More about Syncona Shs GBP
Syncona Limited is a company focused on investing in life sciences with the aim of extending and enhancing human life. They create, build, and scale companies to deliver transformational treatments in areas of high unmet need. Syncona maintains a diversified portfolio of 20-25 globally leading life science businesses, working closely with academic founders and experienced management teams to develop impactful treatments. Their strategy is supported by a strong balance sheet, allowing for long-term investments to improve patient outcomes and deliver risk-adjusted returns to shareholders.
Average Trading Volume: 572,900
Technical Sentiment Signal: Sell
See more insights into SYNC stock on TipRanks’ Stock Analysis page.